PLATELET SEROTONIN, MONOAMINE-OXIDASE ACTIVITY, AND [H-3]PAROXETINE BINDING RELATED TO IMPULSIVE SUICIDE ATTEMPTS AND BORDERLINE PERSONALITY-DISORDER

Citation
Rj. Verkes et al., PLATELET SEROTONIN, MONOAMINE-OXIDASE ACTIVITY, AND [H-3]PAROXETINE BINDING RELATED TO IMPULSIVE SUICIDE ATTEMPTS AND BORDERLINE PERSONALITY-DISORDER, Biological psychiatry, 43(10), 1998, pp. 740-746
Citations number
35
Categorie Soggetti
Psychiatry,Neurosciences
Journal title
ISSN journal
00063223
Volume
43
Issue
10
Year of publication
1998
Pages
740 - 746
Database
ISI
SICI code
0006-3223(1998)43:10<740:PSMAA[>2.0.ZU;2-8
Abstract
Background: The aim of the present study was to examine the relationsh ip between suicidal behavior and impulsiveness, and more generally bor derline personality disorder on the one hand, and platelet indicators of central serotonergic function on the other. Methods: After a suicid e attempt platelet serotonergic measures were obtained from 144 patien ts with at least one previous attempt. A major DSM-III-R Axis I diagno sis and the use of antidepressants were reasons for exclusion. Results : Platelet monoamine oxidase (MAO) activity was negatively correlated with the personality traits ''multi-impulsive behavior'' and ''disinhi bition.'' In accordance, platelet MAO activity was also lower in patie nts with less-planned suicide attempts. Platelet serotonin (5-HT) and recidivism were positively correlated with borderline personality diso rder, in particular chronic feelings of emptiness. Platelet 5-HT was l ower in patients with alcohol abuse. The maximum number of binding sit es (B-max) for paroxetine binding was positively correlated with ''sen sation seeking.'' Conclusions: These findings support the hypothesis t hat serotonergic involvement in impulsive suicidal behavior is mediate d by the relationship between serotonergic function and impulsiveness as personality trait. Other borderline personality traits relevant to recurrent suicidal behavior, in particular chronic feelings of emptine ss, appear also related to serotonergic measures. (C) 1998 Society of Biological Psychiatry.